Sichuan Kelun Pharmaceutical Co., Ltd.
Founded in 1996, Kelun has now formed a "Pin"-shaped architecture operation platform composed of Kelun Pharmaceutical, Chuanning Biotechnology and Kelun Botai, with a total market value of over 100 billion yuan. In 2018, Kelun was named "Manufacturing Single Champion Demonstration Enterprise" for his global advantages in large-capacity injections. Sichuan Kelun Pharmaceutical Co., Ltd. was successfully listed on the Shenzhen Stock Exchange in June 2010, and immediately launched the 10 billion industry investment plan and began to implement the development strategy of "three-in-one developments, innovative growth". The first engine maintains Kelun's leading position in the infusion field through continuous industrial upgrading and variety structure adjustment; the second engine builds from intermediates, raw materials to preparations through innovative development and utilization of high-quality natural resources. The third engine accumulates the ultimate driving force for the everlasting enterprise foundation through the construction of the R&D system and diversified technological innovation. In the field of infusion, Kelun has achieved comprehensive industrial upgrading, and has the profitability of both high-end manufacturing and new materials, occupying a strategic high ground for technological innovation and quality benchmarks. Columbia has established a closed responsibility system from drug research and development, production and manufacturing, logistics and transportation to terminal use to ensure product quality and safety. The leading products have been exported in batches and enjoy a high reputation in more than 50 countries and regions. The stand-up bag® independently developed by Kelun is the first at home and abroad. It has more than 20 patents and has won the National Science and Technology Progress Award. It has higher safety and cost-effectiveness than traditional infusions, and has great application value in reducing energy consumption and environmental protection, representing the direction of development of Chinese infusion products. In the field of antibiotics, the company has established Yili Chuanning Biotechnology Co., Ltd. to produce erythromycin thiocyanate and cephalosporin series intermediates. Through R&D testing, upgrading and optimization, innovative cooperation, and the introduction of advanced domestic and foreign technology equipment, Sichuan Ning has been approved to build a National Environmental Protection Antibiotic Bacterial Slag Harmless Treatment and Resource Utilization Engineering Technology Center, solving the source problems of the antibiotic industry. In December 2022, Chuanning Biotech was successfully listed on the Shenzhen Stock Exchange GEM and entered the field of synthetic biology. Kelun has applied for more than 1,300 invention patents and obtained more than 700 invention patents. He has launched the development of more than 500 major drugs in many diseases such as tumors, bacterial infections, parenteral nutrition, etc.; since 2017, it has been approved for marketing every year. More than 20 items have become the leading generic drug enterprise in China, and has become the leading supplier of national centralized drug procurement with a winning rate of nearly 90%. At the same time, more than ten innovations are used to treat major diseases such as tumors, autoimmunity, inflammation, and metabolism. The drug project is in its clinical stage, with multiple clinical trials being a global multi-center research. Multiple projects work together with European and American partners to deploy global clinical research and are carried out simultaneously in multiple countries including China and Europe and the United States to achieve the synergy of pipelines and technology platforms. Effects, maximize the global value of pipelines.
Sichuan Kelun Pharmaceutical Co., Ltd.
Founded in 1996, Kelun has now formed a "Pin"-shaped architecture operation platform composed of Kelun Pharmaceutical, Chuanning Biotechnology and Kelun Botai, with a total market value of over 100 billion yuan. In 2018, Kelun was named "Manufacturing Single Champion Demonstration Enterprise" for his global advantages in large-capacity injections. Sichuan Kelun Pharmaceutical Co., Ltd. was successfully listed on the Shenzhen Stock Exchange in June 2010, and immediately launched the 10 billion industry investment plan and began to implement the development strategy of "three-in-one developments, innovative growth". The first engine maintains Kelun's leading position in the infusion field through continuous industrial upgrading and variety structure adjustment; the second engine builds from intermediates, raw materials to preparations through innovative development and utilization of high-quality natural resources. The third engine accumulates the ultimate driving force for the everlasting enterprise foundation through the construction of the R&D system and diversified technological innovation. In the field of infusion, Kelun has achieved comprehensive industrial upgrading, and has the profitability of both high-end manufacturing and new materials, occupying a strategic high ground for technological innovation and quality benchmarks. Columbia has established a closed responsibility system from drug research and development, production and manufacturing, logistics and transportation to terminal use to ensure product quality and safety. The leading products have been exported in batches and enjoy a high reputation in more than 50 countries and regions. The stand-up bag® independently developed by Kelun is the first at home and abroad. It has more than 20 patents and has won the National Science and Technology Progress Award. It has higher safety and cost-effectiveness than traditional infusions, and has great application value in reducing energy consumption and environmental protection, representing the direction of development of Chinese infusion products. In the field of antibiotics, the company has established Yili Chuanning Biotechnology Co., Ltd. to produce erythromycin thiocyanate and cephalosporin series intermediates. Through R&D testing, upgrading and optimization, innovative cooperation, and the introduction of advanced domestic and foreign technology equipment, Sichuan Ning has been approved to build a National Environmental Protection Antibiotic Bacterial Slag Harmless Treatment and Resource Utilization Engineering Technology Center, solving the source problems of the antibiotic industry. In December 2022, Chuanning Biotech was successfully listed on the Shenzhen Stock Exchange GEM and entered the field of synthetic biology. Kelun has applied for more than 1,300 invention patents and obtained more than 700 invention patents. He has launched the development of more than 500 major drugs in many diseases such as tumors, bacterial infections, parenteral nutrition, etc.; since 2017, it has been approved for marketing every year. More than 20 items have become the leading generic drug enterprise in China, and has become the leading supplier of national centralized drug procurement with a winning rate of nearly 90%. At the same time, more than ten innovations are used to treat major diseases such as tumors, autoimmunity, inflammation, and metabolism. The drug project is in its clinical stage, with multiple clinical trials being a global multi-center research. Multiple projects work together with European and American partners to deploy global clinical research and are carried out simultaneously in multiple countries including China and Europe and the United States to achieve the synergy of pipelines and technology platforms. Effects, maximize the global value of pipelines.
Henan Tuoren Medical Devices Group Co., Ltd.
Founded in 1993, Tuo Ren Group is a modern group enterprise integrating R&D, production, sales, service and culture. It mainly focuses on medical devices, covering four major sectors: medical business, big health business, international business and industrial new city. There are 5 production bases and 1 research institute, with more than 10,000 employees and more than 500 disabled employees. The medical business involves anesthesia, nursing, surgery, interventional, pain, testing, siatric materials, blood purification and other fields, covering consumables and small and medium-sized equipment, with 431 registration certificates, 30,000 products, and annual sales revenue of more than 6 billion yuan. The group's leading product anesthesia package has a domestic market share of 48%, and the infusion pump has a domestic market share of 36%. International subsidiaries are established in India, Kenya, Uganda, Tanzania, Thailand and other regions, and are exported to 78 countries and regions around the world. The research institute was established in 2008, with a scientific research team of more than 1,050 people, forming a young, efficient and innovative talent team. It cooperates with many well-known universities and research institutes to continuously improve the group's scientific research capabilities and provide corporate talents. The cultivation of the platform and opportunities are provided. It has undertaken and participated in more than 20 national and provincial and ministerial science and technology program projects, has more than 1,500 independent intellectual property rights, more than 80 scientific and technological awards, participated in the formulation and revision of 78 standards, has been recognized by the national CMA and CNAS, and has been awarded the National Biological Industry. More than 110 national and provincial honors including medical materials production and application demonstration platform, postdoctoral research workstation, etc. Tuo Ren Group has continuously improved its technical core and set active equipment as its development direction. Currently, palm ultrasound, color ultrasound diagnostic system, hemodialysis equipment, ultrasound soft tissue surgical equipment and other equipment are on the market. In the future, it will be developing more active medical devices such as anesthesia and nursing in Zhengzhou Camel Industrial Park (located in the core area of Binhe International New City, Zhengzhou Economic and Technological Development Zone, with production, pilot, R&D, office, display and other functions). High-end medical equipment provides clinical convenience and protects patients' health! In addition, the group actively invested in public welfare undertakings, investing 200 million yuan to build a 16,000-square-meter medical museum and the China Medical Device Museum; and donated a total of more than 200 million yuan in various public welfare undertakings. Tuo Ren has always adhered to the values of "customer-centered and struggle-oriented" and contributed to the prosperity of the motherland and the revitalization of national industry with the corporate spirit of "focusing on persistence and forging ahead".
Henan Tuoren Medical Devices Group Co., Ltd.
Founded in 1993, Tuo Ren Group is a modern group enterprise integrating R&D, production, sales, service and culture. It mainly focuses on medical devices, covering four major sectors: medical business, big health business, international business and industrial new city. There are 5 production bases and 1 research institute, with more than 10,000 employees and more than 500 disabled employees. The medical business involves anesthesia, nursing, surgery, interventional, pain, testing, siatric materials, blood purification and other fields, covering consumables and small and medium-sized equipment, with 431 registration certificates, 30,000 products, and annual sales revenue of more than 6 billion yuan. The group's leading product anesthesia package has a domestic market share of 48%, and the infusion pump has a domestic market share of 36%. International subsidiaries are established in India, Kenya, Uganda, Tanzania, Thailand and other regions, and are exported to 78 countries and regions around the world. The research institute was established in 2008, with a scientific research team of more than 1,050 people, forming a young, efficient and innovative talent team. It cooperates with many well-known universities and research institutes to continuously improve the group's scientific research capabilities and provide corporate talents. The cultivation of the platform and opportunities are provided. It has undertaken and participated in more than 20 national and provincial and ministerial science and technology program projects, has more than 1,500 independent intellectual property rights, more than 80 scientific and technological awards, participated in the formulation and revision of 78 standards, has been recognized by the national CMA and CNAS, and has been awarded the National Biological Industry. More than 110 national and provincial honors including medical materials production and application demonstration platform, postdoctoral research workstation, etc. Tuo Ren Group has continuously improved its technical core and set active equipment as its development direction. Currently, palm ultrasound, color ultrasound diagnostic system, hemodialysis equipment, ultrasound soft tissue surgical equipment and other equipment are on the market. In the future, it will be developing more active medical devices such as anesthesia and nursing in Zhengzhou Camel Industrial Park (located in the core area of Binhe International New City, Zhengzhou Economic and Technological Development Zone, with production, pilot, R&D, office, display and other functions). High-end medical equipment provides clinical convenience and protects patients' health! In addition, the group actively invested in public welfare undertakings, investing 200 million yuan to build a 16,000-square-meter medical museum and the China Medical Device Museum; and donated a total of more than 200 million yuan in various public welfare undertakings. Tuo Ren has always adhered to the values of "customer-centered and struggle-oriented" and contributed to the prosperity of the motherland and the revitalization of national industry with the corporate spirit of "focusing on persistence and forging ahead".
Berlang Medical (Shanghai) International Trade Co., Ltd.
The Berlan Group was founded in 1839 in the Meltsonggen region of Germany, with more than 66,000 employees in 64 countries around the world. After nearly two centuries of ups and downs and silent inheritance by several generations, Berlan has become the world's advanced medical equipment, medical products and services provider today, committed to infusion, anesthesia, dialysis, neurosurgery, spinal surgery, Provide solutions in related treatment areas such as diabetes care, clinical nutrition, wound management, infection prevention, etc. By having constructive dialogue with customers and partners, Berlan continuously develops high-quality innovative products and services for the healthcare system, thereby protecting and improving the health of human beings around the world. In 1985, Berlan established a branch in Hong Kong, China and officially launched its business in Greater China. After more than 30 years of development, Berlan has seven independent legal entities in China, headquartered in Shanghai, with branches in major Chinese cities such as Beijing, Guangzhou, and Wuhan. Its business covers more than 70 cities across the country and is in Jiangsu. Suzhou and Zibo, Shandong have invested in the construction of large production bases.
Berlang Medical (Shanghai) International Trade Co., Ltd.
The Berlan Group was founded in 1839 in the Meltsonggen region of Germany, with more than 66,000 employees in 64 countries around the world. After nearly two centuries of ups and downs and silent inheritance by several generations, Berlan has become the world's advanced medical equipment, medical products and services provider today, committed to infusion, anesthesia, dialysis, neurosurgery, spinal surgery, Provide solutions in related treatment areas such as diabetes care, clinical nutrition, wound management, infection prevention, etc. By having constructive dialogue with customers and partners, Berlan continuously develops high-quality innovative products and services for the healthcare system, thereby protecting and improving the health of human beings around the world. In 1985, Berlan established a branch in Hong Kong, China and officially launched its business in Greater China. After more than 30 years of development, Berlan has seven independent legal entities in China, headquartered in Shanghai, with branches in major Chinese cities such as Beijing, Guangzhou, and Wuhan. Its business covers more than 70 cities across the country and is in Jiangsu. Suzhou and Zibo, Shandong have invested in the construction of large production bases.
Jiangxi Sanxin Medical Technology Co., Ltd.
Jiangxi Sanxin Medical Technology Co., Ltd. (hereinafter referred to as Sanxin Medical, stock code: 300453) was founded in Sanjiang Town, Nanchang County in 1997. In 2003, it settled in Xiaolan Economic and Technological Development Zone. It is specialized in the research and development, manufacturing and sales of medical devices. The national high-tech enterprise that serves is a company listed on the A-share market in Jiangxi Province. As the leading unit of the Jiangxi Province High-performance Medical Device Industry Science and Technology Innovation Consortium, it guides the high-quality development of the Jiangxi Province medical device industry with practical actions and research results. The company is also an important member of multiple standardization technical committees such as national medical external circulation equipment, national medical syringes (needles), national infusion devices, etc., presided over and participated in the drafting of 15 national standards and industry standards.
Jiangxi Sanxin Medical Technology Co., Ltd.
Jiangxi Sanxin Medical Technology Co., Ltd. (hereinafter referred to as Sanxin Medical, stock code: 300453) was founded in Sanjiang Town, Nanchang County in 1997. In 2003, it settled in Xiaolan Economic and Technological Development Zone. It is specialized in the research and development, manufacturing and sales of medical devices. The national high-tech enterprise that serves is a company listed on the A-share market in Jiangxi Province. As the leading unit of the Jiangxi Province High-performance Medical Device Industry Science and Technology Innovation Consortium, it guides the high-quality development of the Jiangxi Province medical device industry with practical actions and research results. The company is also an important member of multiple standardization technical committees such as national medical external circulation equipment, national medical syringes (needles), national infusion devices, etc., presided over and participated in the drafting of 15 national standards and industry standards.
Shengang Medical Products Co., Ltd.
Shengguang Medical Products Co., Ltd. is a professional comprehensive production enterprise in the field of medical devices. It was founded in 1993 and achieved rapid large-scale development after its acquisition and restructuring in 2000. Over the past 28 years, the company has been based in the industries of medical devices, medical consumables, rehabilitation devices, health care devices, etc., and has always focused on the field of treatment and rehabilitation, constantly scientific practice, innovative development, improve the industrial chain, and meticulously cultivate product quality. The company adheres to the core concept of "making human beings healthier and wishing a better life", and provides medical products and medical services integrating treatment and rehabilitation for patients around the world, so that the overall strength of the company continues to increase, and the corporate culture and brand influence are deeply rooted in the hearts of the people. The company has rich experience in research and development, manufacturing, experimental inspection and quality control of disposable medical devices. There are 398 engineering and technical personnel in the R&D team, including 128 middle and senior technicians and 4 foreign experts. The company mainly produces 233 product series products including disposable infusion devices, disposable syringes, disposable intravenous needles, disposable precision filtration infusion devices, sanitary materials, anesthesia and other products. The company's products have passed the EU CE certification and ISO9001 and ISO13485 international quality management system certification, and meet the national CMD quality inspection standards. Products are sold well in more than 30 provinces and cities, and are exported to 81 countries and regions including the United Kingdom, the United States, Germany and Southeast Asia. They have established well-known foreign companies such as Baxter, Bidi, Germany Berlan and Japan Mishawa Co., Ltd. Product cooperation relationship enjoys a good reputation at home and abroad. The company is forward-looking and creatively designed to create a new product research and development system that combines industry, education, research and technology, and integrates science, industry and trade. It adheres to the principle of science, technology as the leader and innovation as the soul, and has successively cooperated with Beijing University of Chemical Technology, Jinan University and other countries' "211 Projects" We have cooperated with the "985 Innovation Platform" universities in advantageous areas and invested in the establishment of scientific research institutions such as the "Joint R&D Center for Application of Medical Polymer Materials" and the "Joint R&D Center for Life Science and Technology". Up to now, the company has obtained 52 patents, obtained one of the provincial major science and technology projects, and has been approved by the Henan Provincial Department of Science and Technology as the "Henan Province Minimally Invasive Intervention and Infusion Medical Device Engineering Technology Research Center". At the same time, the company is applying for a national enterprise technology center. Looking back on the past, we have a lot of results, and looking forward to the future, we have a long way to go. On the road to promoting the healthy development of enterprises and benefiting mankind, the Holy Light will continue to be enterprising and make great strides.
Shengang Medical Products Co., Ltd.
Shengguang Medical Products Co., Ltd. is a professional comprehensive production enterprise in the field of medical devices. It was founded in 1993 and achieved rapid large-scale development after its acquisition and restructuring in 2000. Over the past 28 years, the company has been based in the industries of medical devices, medical consumables, rehabilitation devices, health care devices, etc., and has always focused on the field of treatment and rehabilitation, constantly scientific practice, innovative development, improve the industrial chain, and meticulously cultivate product quality. The company adheres to the core concept of "making human beings healthier and wishing a better life", and provides medical products and medical services integrating treatment and rehabilitation for patients around the world, so that the overall strength of the company continues to increase, and the corporate culture and brand influence are deeply rooted in the hearts of the people. The company has rich experience in research and development, manufacturing, experimental inspection and quality control of disposable medical devices. There are 398 engineering and technical personnel in the R&D team, including 128 middle and senior technicians and 4 foreign experts. The company mainly produces 233 product series products including disposable infusion devices, disposable syringes, disposable intravenous needles, disposable precision filtration infusion devices, sanitary materials, anesthesia and other products. The company's products have passed the EU CE certification and ISO9001 and ISO13485 international quality management system certification, and meet the national CMD quality inspection standards. Products are sold well in more than 30 provinces and cities, and are exported to 81 countries and regions including the United Kingdom, the United States, Germany and Southeast Asia. They have established well-known foreign companies such as Baxter, Bidi, Germany Berlan and Japan Mishawa Co., Ltd. Product cooperation relationship enjoys a good reputation at home and abroad. The company is forward-looking and creatively designed to create a new product research and development system that combines industry, education, research and technology, and integrates science, industry and trade. It adheres to the principle of science, technology as the leader and innovation as the soul, and has successively cooperated with Beijing University of Chemical Technology, Jinan University and other countries' "211 Projects" We have cooperated with the "985 Innovation Platform" universities in advantageous areas and invested in the establishment of scientific research institutions such as the "Joint R&D Center for Application of Medical Polymer Materials" and the "Joint R&D Center for Life Science and Technology". Up to now, the company has obtained 52 patents, obtained one of the provincial major science and technology projects, and has been approved by the Henan Provincial Department of Science and Technology as the "Henan Province Minimally Invasive Intervention and Infusion Medical Device Engineering Technology Research Center". At the same time, the company is applying for a national enterprise technology center. Looking back on the past, we have a lot of results, and looking forward to the future, we have a long way to go. On the road to promoting the healthy development of enterprises and benefiting mankind, the Holy Light will continue to be enterprising and make great strides.
Terumo (China) Investment Co., Ltd.
Import channels were interrupted during World War I, and Japanese medical scientists made efforts to localize the thermometers as their goal. In 1921, medical scientists led by Dr. Shibasaburo Kitari founded the Telmao Company. Since its establishment, Termau has inherited the innovative challenge spirit of Dr. Beili, implemented the company philosophy of "contributing to society through medical care", and is committed to delivering excellent innovative technologies to the medical site. Telmao Co., Ltd. was founded in 1921. Its products include disposable medical devices, blood transfusion tools series, pharmaceutical and nutritional medicine series, angiography and therapeutic catheter, medical electronic products series, artificial heart and lung product series, etc. Termau's products have been widely used in many countries and regions around the world. Termau's unique technology will make the medical process humanized and gentle. The application of Telmao's new technology can relieve pain and discomfort during medical treatment as much as possible. Telmau has always been committed to developing medical products that meet high standards, not only meeting high standards in terms of safety and precision, but also in maintaining patients' good recovery and quality of life. At present, Telmao has established two factories in Hangzhou and Changchun, China respectively. Termau will dedicate mild, easy-to-use healthcare products and technologies to the world in the 21st century. In order to strengthen the integrated management of R&D, production and sales in China, Telmao applied for the establishment of Telmao (China) Investment Co., Ltd. in August 2012, with a registered capital of US$30 million. According to the early business strategy, the sales ratio of domestic products will be gradually increased in the future. The establishment of Telmao (China) Investment Co., Ltd. has also taken a big step to integrating the Greater China Circle Management Model in the Mainland, Hong Kong, Macau and Taiwan markets.
Terumo (China) Investment Co., Ltd.
Import channels were interrupted during World War I, and Japanese medical scientists made efforts to localize the thermometers as their goal. In 1921, medical scientists led by Dr. Shibasaburo Kitari founded the Telmao Company. Since its establishment, Termau has inherited the innovative challenge spirit of Dr. Beili, implemented the company philosophy of "contributing to society through medical care", and is committed to delivering excellent innovative technologies to the medical site. Telmao Co., Ltd. was founded in 1921. Its products include disposable medical devices, blood transfusion tools series, pharmaceutical and nutritional medicine series, angiography and therapeutic catheter, medical electronic products series, artificial heart and lung product series, etc. Termau's products have been widely used in many countries and regions around the world. Termau's unique technology will make the medical process humanized and gentle. The application of Telmao's new technology can relieve pain and discomfort during medical treatment as much as possible. Telmau has always been committed to developing medical products that meet high standards, not only meeting high standards in terms of safety and precision, but also in maintaining patients' good recovery and quality of life. At present, Telmao has established two factories in Hangzhou and Changchun, China respectively. Termau will dedicate mild, easy-to-use healthcare products and technologies to the world in the 21st century. In order to strengthen the integrated management of R&D, production and sales in China, Telmao applied for the establishment of Telmao (China) Investment Co., Ltd. in August 2012, with a registered capital of US$30 million. According to the early business strategy, the sales ratio of domestic products will be gradually increased in the future. The establishment of Telmao (China) Investment Co., Ltd. has also taken a big step to integrating the Greater China Circle Management Model in the Mainland, Hong Kong, Macau and Taiwan markets.
Weihai Jierui Medical Products Co., Ltd. was established in 1999 and mainly produces wound care series, ostomy care series, injection puncture series, PVC pellets and TPE pellet series. To develop, produce and sell foam dressings, wound colloidal patches, alginate dressings, silver alginate-containing dressings, silicone gel scar dressings, hydrogel dressings, silver ion antibacterial gels, surgical anti-adhesion products, medical surgery Mainly functional dressings such as glue, it is committed to becoming a large manufacturing company for domestic wound care products, providing clinically professional and integrated complete solutions for wound stoma. Weihai Jierui Medical Products Co., Ltd. will always adhere to the factory construction policy of "innovation, seeking practicality and consolidation", adhere to the mission of "together with white-clothed messengers to create a healthy future", establish the core values of conscience, sincerity and loyalty, and adhere to the " One center, three adjustments”, achieve sustainable development, and strive to build a professional company.
Weigao Group Co., Ltd.
Weihai Jierui Medical Products Co., Ltd. was established in 1999 and mainly produces wound care series, ostomy care series, injection puncture series, PVC pellets and TPE pellet series. To develop, produce and sell foam dressings, wound colloidal patches, alginate dressings, silver alginate-containing dressings, silicone gel scar dressings, hydrogel dressings, silver ion antibacterial gels, surgical anti-adhesion products, medical surgery Mainly functional dressings such as glue, it is committed to becoming a large manufacturing company for domestic wound care products, providing clinically professional and integrated complete solutions for wound stoma. Weihai Jierui Medical Products Co., Ltd. will always adhere to the factory construction policy of "innovation, seeking practicality and consolidation", adhere to the mission of "together with white-clothed messengers to create a healthy future", establish the core values of conscience, sincerity and loyalty, and adhere to the " One center, three adjustments”, achieve sustainable development, and strive to build a professional company.
Shandong Ande Medical Products Co., Ltd.
Shandong Ande Medical Supplies Co., Ltd. (hereinafter referred to as Ande Medical) is a Sino-French joint venture located in Zibo City, Shandong Province, the hometown of Qi culture in China. Ande Medical is committed to the research, development, production and sales of a series of products such as vascular access, infusion treatment, enteral nutrition treatment, medical test specimen collection, modern wound care and surgical drainage. Ande Medical focuses on technological innovation, develops clinically valuable products and provides overall solutions, and currently has more than 120 patents. Ande Medical has passed the ISO9001 and ISO13485 quality system certification and CNAS laboratory certification from TUV São, and its main products have obtained FDA certification and CE certification. As a leading medical consumables enterprise in China, Ande Medical promotes lean production and intelligent manufacturing, continuously improves and improves the customer service system, and is committed to providing medical institutions with safe and advanced sterile medical devices to serve the cause of human health.
Shandong Ande Medical Products Co., Ltd.
Shandong Ande Medical Supplies Co., Ltd. (hereinafter referred to as Ande Medical) is a Sino-French joint venture located in Zibo City, Shandong Province, the hometown of Qi culture in China. Ande Medical is committed to the research, development, production and sales of a series of products such as vascular access, infusion treatment, enteral nutrition treatment, medical test specimen collection, modern wound care and surgical drainage. Ande Medical focuses on technological innovation, develops clinically valuable products and provides overall solutions, and currently has more than 120 patents. Ande Medical has passed the ISO9001 and ISO13485 quality system certification and CNAS laboratory certification from TUV São, and its main products have obtained FDA certification and CE certification. As a leading medical consumables enterprise in China, Ande Medical promotes lean production and intelligent manufacturing, continuously improves and improves the customer service system, and is committed to providing medical institutions with safe and advanced sterile medical devices to serve the cause of human health.
Smith Medical Devices (Beijing) Co., Ltd.
ICU Medical was founded in 1984 and is headquartered in San Clemente, California. In 1992, the company issued its initial public offering of shares on Nasdaq (NASDAQ:ICUI). ICU Medical's main customers include: hospital emergency departments, wholesalers, mobile clinics, outpatient clinics, home health care and long-term care supply institutions, etc. Since its establishment, ICU company has maintained organic growth and extended its business to more than 90 countries and regions around the world through acquisitions. After more than 30 years of development, ICU Medical has now become one of the world's advanced infusion therapy companies (pure-play infusion therapy companies), with business covering more than 90 countries and regions around the world. The company's products include infusion solutions, smart infusion pumps, dedicated and non-special infusion kits and needle-free connectors, as well as pain management and safety software technologies designed to help achieve clinical, safety and workflow goals. In addition, ICU also manufactured the world's first needle-free automated infusion dispensing system with its advanced workflow technology, closed system transmission equipment (for equipped with hazardous infusion drugs) and cardiac monitoring system. The current business composition ratio of ICU is about: infusion consumables account for 40%; infusion systems account for 30%, infusion solutions account for 25%, and intensive care accounts for 5%. Among them, infusion consumables mainly include: gravity equipment, needleless intravenous injection connectors, as well as closed system transmission equipment and special infusion consumables. The infusion system includes: large-capacity and outpatient intravenous injection pumps, special infusion sets, electronic medical record interactive security software and on-site services. Infusion solutions include: disinfection solutions, infusion irrigation solutions and some nutritional solutions. Intensive care includes: hemodynamic monitoring systems for evaluating patient blood flow status, advanced sensors and catheters, and pressure sensors. ICU Medical's medical consumables always account for a high proportion of its product portfolio, ensuring that the company has always had good financial indicators. ICU Medical has direct branches in North America (USA, Canada), South America (Argentina, Chile, Peru, Colombia), Europe, the United Kingdom, South Africa, Australia and other regions, including China, India, Russia, Central Asia, Dealer channels are set up in Nordic countries and regions. In terms of production, ICU Medical has 4 factories, including 3 in the United States and 1 in Costa Rica. Among them, ICU Medical's investment in the Costa Ri processing plant reached US$13.2 million. In addition to producing more than 800 venous devices, the plant also produces award-winning Plum 360 and LifeCare PCA infusion pumps.
Smith Medical Devices (Beijing) Co., Ltd.
ICU Medical was founded in 1984 and is headquartered in San Clemente, California. In 1992, the company issued its initial public offering of shares on Nasdaq (NASDAQ:ICUI). ICU Medical's main customers include: hospital emergency departments, wholesalers, mobile clinics, outpatient clinics, home health care and long-term care supply institutions, etc. Since its establishment, ICU company has maintained organic growth and extended its business to more than 90 countries and regions around the world through acquisitions. After more than 30 years of development, ICU Medical has now become one of the world's advanced infusion therapy companies (pure-play infusion therapy companies), with business covering more than 90 countries and regions around the world. The company's products include infusion solutions, smart infusion pumps, dedicated and non-special infusion kits and needle-free connectors, as well as pain management and safety software technologies designed to help achieve clinical, safety and workflow goals. In addition, ICU also manufactured the world's first needle-free automated infusion dispensing system with its advanced workflow technology, closed system transmission equipment (for equipped with hazardous infusion drugs) and cardiac monitoring system. The current business composition ratio of ICU is about: infusion consumables account for 40%; infusion systems account for 30%, infusion solutions account for 25%, and intensive care accounts for 5%. Among them, infusion consumables mainly include: gravity equipment, needleless intravenous injection connectors, as well as closed system transmission equipment and special infusion consumables. The infusion system includes: large-capacity and outpatient intravenous injection pumps, special infusion sets, electronic medical record interactive security software and on-site services. Infusion solutions include: disinfection solutions, infusion irrigation solutions and some nutritional solutions. Intensive care includes: hemodynamic monitoring systems for evaluating patient blood flow status, advanced sensors and catheters, and pressure sensors. ICU Medical's medical consumables always account for a high proportion of its product portfolio, ensuring that the company has always had good financial indicators. ICU Medical has direct branches in North America (USA, Canada), South America (Argentina, Chile, Peru, Colombia), Europe, the United Kingdom, South Africa, Australia and other regions, including China, India, Russia, Central Asia, Dealer channels are set up in Nordic countries and regions. In terms of production, ICU Medical has 4 factories, including 3 in the United States and 1 in Costa Rica. Among them, ICU Medical's investment in the Costa Ri processing plant reached US$13.2 million. In addition to producing more than 800 venous devices, the plant also produces award-winning Plum 360 and LifeCare PCA infusion pumps.
BD Medical Devices (Shanghai) Co., Ltd.
Bidi Medical is a global medical technology company that leads the world's health by improving medical discovery methods, medical diagnostic effects and care quality. Bidi Medical focuses and supports every front-line medical worker, and is committed to helping patients improve clinical treatment through the development of innovative technologies, services and solutions, and helping medical staff improve clinical processes. Beddy Medical and its 75,000 global employees uphold a high level of enthusiasm and belief to provide clinical medical staff with a safe and efficient nursing delivery process, assist laboratory scientists in diagnosing diseases more effectively, and enhance the research and development of a new generation of diagnosis and Ability to treat diseases. Bidi Medical has branches in almost all countries and actively cooperates with organizations around the world to work together to address challenging global health issues. Through close collaboration with customers, Bidi Medical takes it as its mission to improve treatment outcomes, reduce medical costs, and improve diagnostic efficiency, helping to strengthen the safety of patients and medical staff and expand medical access. In 1994, Bidi Medical officially sent personnel to register and establish a representative agency in China to carry out business with China. Currently, it has formed a regional headquarters with Shanghai, with offices in cities such as Beijing, Guangzhou, and Chengdu, with nearly 4,000 employees. In the past 30 years, Bidi Medical has adhered to the concept of "rooted in China, serving China" (In China, For China), and is committed to building high-quality local multinational medical technology companies, with a total investment of hundreds of millions of dollars and building three major local factories. 2 R&D centers and 1 customer service center, and a customer experience center, several professional training centers and laboratories, as well as the comprehensive Bidi Medical Greater China Innovation Center officially completed in 2023, actively practicing health care China 2030 will benefit more Chinese patients and medical workers and help promote the progress of medical industry.
BD Medical Devices (Shanghai) Co., Ltd.
Bidi Medical is a global medical technology company that leads the world's health by improving medical discovery methods, medical diagnostic effects and care quality. Bidi Medical focuses and supports every front-line medical worker, and is committed to helping patients improve clinical treatment through the development of innovative technologies, services and solutions, and helping medical staff improve clinical processes. Beddy Medical and its 75,000 global employees uphold a high level of enthusiasm and belief to provide clinical medical staff with a safe and efficient nursing delivery process, assist laboratory scientists in diagnosing diseases more effectively, and enhance the research and development of a new generation of diagnosis and Ability to treat diseases. Bidi Medical has branches in almost all countries and actively cooperates with organizations around the world to work together to address challenging global health issues. Through close collaboration with customers, Bidi Medical takes it as its mission to improve treatment outcomes, reduce medical costs, and improve diagnostic efficiency, helping to strengthen the safety of patients and medical staff and expand medical access. In 1994, Bidi Medical officially sent personnel to register and establish a representative agency in China to carry out business with China. Currently, it has formed a regional headquarters with Shanghai, with offices in cities such as Beijing, Guangzhou, and Chengdu, with nearly 4,000 employees. In the past 30 years, Bidi Medical has adhered to the concept of "rooted in China, serving China" (In China, For China), and is committed to building high-quality local multinational medical technology companies, with a total investment of hundreds of millions of dollars and building three major local factories. 2 R&D centers and 1 customer service center, and a customer experience center, several professional training centers and laboratories, as well as the comprehensive Bidi Medical Greater China Innovation Center officially completed in 2023, actively practicing health care China 2030 will benefit more Chinese patients and medical workers and help promote the progress of medical industry.
Fujian Baishiwei Medical Polymer Co., Ltd.
Fujian Baishiwei Medical Polymer Co., Ltd. was founded by Mr. Chen Yongxi on January 6, 2006. It integrates R&D, production and sales. It is a large-scale manufacturer specializing in the research and development and production of medical device products such as indwelling needles and medical catheters. The company has a subsidiary Fuzhou Conlit Medical Device Co., Ltd. The company headquarters has a total of ten departments: General Administration Office, Management Department, Quality Department, Technology R&D Department, Process Department, Production Department, Material Department, International Business Department, Sales Operation Department, and Finance Department. The company has gathered a high-level professional R&D team led by Chen Yongxi to lead Besvia to become the world's leading innovation leader in medical infusion industry. The company has always adhered to the business philosophy of "people-oriented and harmonious development", adhered to the belief of benefiting people's livelihood, and exported products to dozens of countries and regions such as America, Europe, the Middle East, and Asia. The domestic market has also accumulated strength and gradually developed into a leader in Chinese national brands. Bestway regards product quality as life, and the company has passed ISO9001, ISO13485, EU CE and other systems certification. It also has a sterile sterile factory and laboratory with a level of more than 8,000 square meters. Currently, they hold 137 national patents, including 25 invention patents, 30 utility model patent applications, and 82 international PCT patent applications.
Fujian Baishiwei Medical Polymer Co., Ltd.
Fujian Baishiwei Medical Polymer Co., Ltd. was founded by Mr. Chen Yongxi on January 6, 2006. It integrates R&D, production and sales. It is a large-scale manufacturer specializing in the research and development and production of medical device products such as indwelling needles and medical catheters. The company has a subsidiary Fuzhou Conlit Medical Device Co., Ltd. The company headquarters has a total of ten departments: General Administration Office, Management Department, Quality Department, Technology R&D Department, Process Department, Production Department, Material Department, International Business Department, Sales Operation Department, and Finance Department. The company has gathered a high-level professional R&D team led by Chen Yongxi to lead Besvia to become the world's leading innovation leader in medical infusion industry. The company has always adhered to the business philosophy of "people-oriented and harmonious development", adhered to the belief of benefiting people's livelihood, and exported products to dozens of countries and regions such as America, Europe, the Middle East, and Asia. The domestic market has also accumulated strength and gradually developed into a leader in Chinese national brands. Bestway regards product quality as life, and the company has passed ISO9001, ISO13485, EU CE and other systems certification. It also has a sterile sterile factory and laboratory with a level of more than 8,000 square meters. Currently, they hold 137 national patents, including 25 invention patents, 30 utility model patent applications, and 82 international PCT patent applications.
Shanghai Kindly Enterprise Development Group Co., Ltd.
Shanghai Condelay Enterprise Development Group Co., Ltd. (hereinafter referred to as: Condelay; stock code 603987), Condelay was founded in Wenzhou in 1987. Condelay's headquarters is located at No. 658, Gaochao Road, Jiangqiao Town, Jiading District, Shanghai, mainly engaged in medical puncture. The research and development, production and sales of devices are mainly medical puncture needles and medical puncture devices. The company is a cutting-edge enterprise in domestic medical puncture needle manufacturing technology and one of the few domestic manufacturers with a complete industrial chain of medical puncture devices. As the parent company of Condelay listed company, through capital operations and industrial operations, the company currently has more than 50 subsidiaries, all of which are medical puncture products production and operation and distribution enterprises. In terms of industry status, the company is not only responsible for/participated in the drafting of disposable infusion devices, blood transfusion devices, syringes, injection needles, intravenous infusion needles, medical stainless syringes, and six national standards, but also participated in the drafting of disposable anesthesia needles. , drafting of thirteen industry standards, including special needles for implantable drug delivery devices, biopsy needles, intravenous indwelling needles, sterile dental injection needles, dental cartridge syringes, and final sterilized medical device packaging materials. The company has established a complete medical device quality management system in accordance with national regulations based on the quality policy of "creating KDL brand and winning hundreds of millions of users". At the same time, a scientific research and development system that combines schools and enterprises has also been established, and has obtained more than 200 domestic and international patents. It has been successively recognized as a "high-tech enterprise", "patent demonstration enterprise", "municipal technology research and development center", and "Shanghai" The Municipal Science and Technology Little Giant Enterprise” has received support from Shanghai Torch Plan and Shanghai High-tech Achievements Transformation and other projects on many occasions. The products are sold to provinces, cities, autonomous regions, and municipalities in China, and are exported to more than 50 countries and regions including the United States, Europe, South America, the Middle East, Southeast Asia, etc., and have formed a stable cooperative relationship. "Sympathy, win-win, and common development" is Condelay's unchanging cultural concept. The company will continue to adhere to the positioning of high-quality products and technological innovation, provide high-quality products and services for human health, and work hand in hand with its domestic and foreign counterparts to further develop China's medical and health industry has made new contributions!
Shanghai Kindly Enterprise Development Group Co., Ltd.
Shanghai Condelay Enterprise Development Group Co., Ltd. (hereinafter referred to as: Condelay; stock code 603987), Condelay was founded in Wenzhou in 1987. Condelay's headquarters is located at No. 658, Gaochao Road, Jiangqiao Town, Jiading District, Shanghai, mainly engaged in medical puncture. The research and development, production and sales of devices are mainly medical puncture needles and medical puncture devices. The company is a cutting-edge enterprise in domestic medical puncture needle manufacturing technology and one of the few domestic manufacturers with a complete industrial chain of medical puncture devices. As the parent company of Condelay listed company, through capital operations and industrial operations, the company currently has more than 50 subsidiaries, all of which are medical puncture products production and operation and distribution enterprises. In terms of industry status, the company is not only responsible for/participated in the drafting of disposable infusion devices, blood transfusion devices, syringes, injection needles, intravenous infusion needles, medical stainless syringes, and six national standards, but also participated in the drafting of disposable anesthesia needles. , drafting of thirteen industry standards, including special needles for implantable drug delivery devices, biopsy needles, intravenous indwelling needles, sterile dental injection needles, dental cartridge syringes, and final sterilized medical device packaging materials. The company has established a complete medical device quality management system in accordance with national regulations based on the quality policy of "creating KDL brand and winning hundreds of millions of users". At the same time, a scientific research and development system that combines schools and enterprises has also been established, and has obtained more than 200 domestic and international patents. It has been successively recognized as a "high-tech enterprise", "patent demonstration enterprise", "municipal technology research and development center", and "Shanghai" The Municipal Science and Technology Little Giant Enterprise” has received support from Shanghai Torch Plan and Shanghai High-tech Achievements Transformation and other projects on many occasions. The products are sold to provinces, cities, autonomous regions, and municipalities in China, and are exported to more than 50 countries and regions including the United States, Europe, South America, the Middle East, Southeast Asia, etc., and have formed a stable cooperative relationship. "Sympathy, win-win, and common development" is Condelay's unchanging cultural concept. The company will continue to adhere to the positioning of high-quality products and technological innovation, provide high-quality products and services for human health, and work hand in hand with its domestic and foreign counterparts to further develop China's medical and health industry has made new contributions!
Chengdu Xinjin Shifeng Medical Devices Co., Ltd.
Chengdu Xinjin Shifeng Medical Equipment Co., Ltd. is a leading enterprise in the production of disposable sterile medical equipment series products in western China. The company was founded in 1991. The total assets are RMB 460 million, the number of employees is 1,100, and it has three major production plants: Xinping Production Base, Jinhua Smart Factory, and Pakistan Factory. The business involves the research, development, production and sales of disposable sterile medical device products of more than 100 varieties of disposable sterile medical device products in 53 categories, including disposable infusion devices, bag infusion devices, syringes, injection needles. Currently, there are more than 1,200 employees, 22,000 square meters of purification plant, 6 purification workshops, more than 80 production lines, more than 500 automated production equipment, products cover more than 4,800 hospitals, registered capital of 40.7868 million yuan, now It has nearly 500 million yuan in assets and achieved tax revenue of 57 million yuan in 2020. The company has three major production bases, the Baodun production base in Xinjin District, the Tianfu New District Intelligent Manufacturing Industrial Park production base, and the Lahore factory in Pakistan. Among them, the production base of the Tianfu New District Intelligent Manufacturing Industrial Park is the headquarters of the group. The base widely adopts advanced information technology of intelligent manufacturing, intelligent warehousing, and smart parks, and is based on creating a leading domestic industry benchmark smart factory. Since 1998, the company has gradually built a complete quality management system and a strict internal control system. The company has obtained ISO9001 and ISO13485 quality system certification since 2002. At present, the company has passed ISO9001, ISO13485 quality management system certification, 93/42/EEC EC Directive and U.S. Federal Regulations Code Volume 21, Part 820 (passed the FDA on-site inspection. ), WHO's PQS certification, China Medical Device Quality Management Standard GMP certification, ISO14001 Environmental Management System Certification, and major products have obtained EU CE certification and FDA product registration and filing registration. The company mainly engages in infusion/blood device (TPE, precision, bag type, light-proof, automatic liquid-resistance and other functional types); syringes, feeders, irrigators, extracorporeal blood circulation, arteriovenous puncture needles, indwelling needles, etc. Clinical nursing products; disposable sterile medical device products of more than 120 registered varieties of 54 major categories, including protective clothing, medical protective masks, surgical masks, sanitary dressings, sampling tubes, samplers and other epidemic prevention products series. The company implements group governance and strengthens international cooperation. Give full play to the spirit of craftsmanship, leverage talent advantages, base ourselves in the southwest and go to the world. We will give full play to the company's production and manufacturing advantages, and use the medical device registration and holder system to vigorously carry out OEM and ODM businesses, and strive to build Shifeng into a "world factory" for sterile medical devices. The company will take the four first-class development goals of the company: "creating first-class factories, cultivating first-class talents, manufacturing first-class products, and providing first-class compensation", and make greater contributions to the development and progress of disposable sterile medical devices and human health.
Chengdu Xinjin Shifeng Medical Devices Co., Ltd.
Chengdu Xinjin Shifeng Medical Equipment Co., Ltd. is a leading enterprise in the production of disposable sterile medical equipment series products in western China. The company was founded in 1991. The total assets are RMB 460 million, the number of employees is 1,100, and it has three major production plants: Xinping Production Base, Jinhua Smart Factory, and Pakistan Factory. The business involves the research, development, production and sales of disposable sterile medical device products of more than 100 varieties of disposable sterile medical device products in 53 categories, including disposable infusion devices, bag infusion devices, syringes, injection needles. Currently, there are more than 1,200 employees, 22,000 square meters of purification plant, 6 purification workshops, more than 80 production lines, more than 500 automated production equipment, products cover more than 4,800 hospitals, registered capital of 40.7868 million yuan, now It has nearly 500 million yuan in assets and achieved tax revenue of 57 million yuan in 2020. The company has three major production bases, the Baodun production base in Xinjin District, the Tianfu New District Intelligent Manufacturing Industrial Park production base, and the Lahore factory in Pakistan. Among them, the production base of the Tianfu New District Intelligent Manufacturing Industrial Park is the headquarters of the group. The base widely adopts advanced information technology of intelligent manufacturing, intelligent warehousing, and smart parks, and is based on creating a leading domestic industry benchmark smart factory. Since 1998, the company has gradually built a complete quality management system and a strict internal control system. The company has obtained ISO9001 and ISO13485 quality system certification since 2002. At present, the company has passed ISO9001, ISO13485 quality management system certification, 93/42/EEC EC Directive and U.S. Federal Regulations Code Volume 21, Part 820 (passed the FDA on-site inspection. ), WHO's PQS certification, China Medical Device Quality Management Standard GMP certification, ISO14001 Environmental Management System Certification, and major products have obtained EU CE certification and FDA product registration and filing registration. The company mainly engages in infusion/blood device (TPE, precision, bag type, light-proof, automatic liquid-resistance and other functional types); syringes, feeders, irrigators, extracorporeal blood circulation, arteriovenous puncture needles, indwelling needles, etc. Clinical nursing products; disposable sterile medical device products of more than 120 registered varieties of 54 major categories, including protective clothing, medical protective masks, surgical masks, sanitary dressings, sampling tubes, samplers and other epidemic prevention products series. The company implements group governance and strengthens international cooperation. Give full play to the spirit of craftsmanship, leverage talent advantages, base ourselves in the southwest and go to the world. We will give full play to the company's production and manufacturing advantages, and use the medical device registration and holder system to vigorously carry out OEM and ODM businesses, and strive to build Shifeng into a "world factory" for sterile medical devices. The company will take the four first-class development goals of the company: "creating first-class factories, cultivating first-class talents, manufacturing first-class products, and providing first-class compensation", and make greater contributions to the development and progress of disposable sterile medical devices and human health.
Suzhou Linhua Medical Devices Co., Ltd.
Linhua Medical is located on the banks of the beautiful Yangcheng Lake in Suzhou Industrial Park. It is a high-tech enterprise focusing on the research and development of high-end medical consumables, intelligent manufacturing, professional academic promotion and brand marketing. Lin Hua combined international advanced concepts with Chinese clinical practice to create a " anti-blocking tube and anti-thrombosis " vascular drug delivery system solution. It has been widely recognized by clinical users of major hospitals in China. Linhua Medical has gathered a group of excellent professional and technical talents, possessing more than 100 patented skills, participating in the drafting of a number of industry standards, and is committed to providing clinical users with high-quality products and value-for-money services. Lin Chinese is brave enough to challenge. Under the guidance of the corporate culture of "one family" and the incentive mechanism of "creating and sharing, doing for one's own home", he works together and strives to contribute to the promotion of high-quality development of China's medical device industry.
Suzhou Linhua Medical Devices Co., Ltd.
Linhua Medical is located on the banks of the beautiful Yangcheng Lake in Suzhou Industrial Park. It is a high-tech enterprise focusing on the research and development of high-end medical consumables, intelligent manufacturing, professional academic promotion and brand marketing. Lin Hua combined international advanced concepts with Chinese clinical practice to create a " anti-blocking tube and anti-thrombosis " vascular drug delivery system solution. It has been widely recognized by clinical users of major hospitals in China. Linhua Medical has gathered a group of excellent professional and technical talents, possessing more than 100 patented skills, participating in the drafting of a number of industry standards, and is committed to providing clinical users with high-quality products and value-for-money services. Lin Chinese is brave enough to challenge. Under the guidance of the corporate culture of "one family" and the incentive mechanism of "creating and sharing, doing for one's own home", he works together and strives to contribute to the promotion of high-quality development of China's medical device industry.
Guangdong HyBio Medical Technology Co., Ltd.
Guangdong Baihe Medical Technology Co., Ltd. was founded in 1999 and is located at No. 89 Taoyuan East Road, Shishan Town, Nanhai District, Foshan City. The company's main business is the research, development, production and sales of disposable medical consumables and other medical devices. It is a high-tech enterprise combining modern engineering technology and clinical medicine. It is a strong competition in the field of high-end medical consumables in China that can form a strong competition with foreign products. One of the few companies. The company has advanced domestic medical consumables production technology and technology, a complete quality assurance system, modern management methods, high-quality products and high-quality services. Starting from the central venous catheter and hemodialysis catheter when the company was founded, the company has formed three major fields: intravenous infusion consumables, blood purification consumables, and nurse dressing consumables, and relying on the technical advantages of the three major fields and rich product reserves , become a comprehensive solution provider of disposable medical consumables in the above fields. The company has gathered a high-level professional R&D and technical innovation team led by medical consumables experts. It has sufficient talent reserves, covering medical polymer materials, biomedical engineering, clinical medicine, laboratory medicine, life sciences, biochemistry, materials science, molds, machinery. and many other disciplines. The company's main products include: central venous catheter, hemodialysis catheter, infusion connector, extension tube, plug, indwelling needle, blood circuit, fistula puncture pack, pressure sensor and other three types of medical devices. The company passed ISO13485 certification and EU CE certification in 2003, and passed the US FDA certification in 2007. The company has received attention and support from universities including South China University of Technology, Jinan University, Sun Yat-sen University Affiliated Hospital, Southern Medical University Zhujiang Hospital and other institutions at all levels, and all sectors of society, allowing Lily Medical to conduct basic research and clinical trials of medical catheter products. Smoothly progress and great progress. The company will continue to uphold the value of "focusing on reputation, being responsible for life; pursuing excellence and satisfying customers", adhere to the "user-centered" design concept, and continue to be committed to the research, development, production and sales of disposable medical consumables and other medical devices. . The company will strive for excellence in the spirit of "responsible for patients" and strive to become the world's leading provider of integrated solutions for disposable medical consumables as soon as possible.
Guangdong HyBio Medical Technology Co., Ltd.
Guangdong Baihe Medical Technology Co., Ltd. was founded in 1999 and is located at No. 89 Taoyuan East Road, Shishan Town, Nanhai District, Foshan City. The company's main business is the research, development, production and sales of disposable medical consumables and other medical devices. It is a high-tech enterprise combining modern engineering technology and clinical medicine. It is a strong competition in the field of high-end medical consumables in China that can form a strong competition with foreign products. One of the few companies. The company has advanced domestic medical consumables production technology and technology, a complete quality assurance system, modern management methods, high-quality products and high-quality services. Starting from the central venous catheter and hemodialysis catheter when the company was founded, the company has formed three major fields: intravenous infusion consumables, blood purification consumables, and nurse dressing consumables, and relying on the technical advantages of the three major fields and rich product reserves , become a comprehensive solution provider of disposable medical consumables in the above fields. The company has gathered a high-level professional R&D and technical innovation team led by medical consumables experts. It has sufficient talent reserves, covering medical polymer materials, biomedical engineering, clinical medicine, laboratory medicine, life sciences, biochemistry, materials science, molds, machinery. and many other disciplines. The company's main products include: central venous catheter, hemodialysis catheter, infusion connector, extension tube, plug, indwelling needle, blood circuit, fistula puncture pack, pressure sensor and other three types of medical devices. The company passed ISO13485 certification and EU CE certification in 2003, and passed the US FDA certification in 2007. The company has received attention and support from universities including South China University of Technology, Jinan University, Sun Yat-sen University Affiliated Hospital, Southern Medical University Zhujiang Hospital and other institutions at all levels, and all sectors of society, allowing Lily Medical to conduct basic research and clinical trials of medical catheter products. Smoothly progress and great progress. The company will continue to uphold the value of "focusing on reputation, being responsible for life; pursuing excellence and satisfying customers", adhere to the "user-centered" design concept, and continue to be committed to the research, development, production and sales of disposable medical consumables and other medical devices. . The company will strive for excellence in the spirit of "responsible for patients" and strive to become the world's leading provider of integrated solutions for disposable medical consumables as soon as possible.
Nipro Trading (Shanghai) Co., Ltd.
NIPRO is at the forefront of global medical care and constantly challenges the unknown areas of life sciences. With persistent commitment to the research and development and innovation of cutting-edge medical products, NIPRO has been able to provide excellent technologies and products for various fields such as medical equipment and medicines. A variety of patented technologies used in artificial kidneys and various disposable medical devices give this medical product unprecedented functions and characteristics. NIPRO has also carried out close cooperation with many multinational pharmaceutical companies (Pfizer, Novartis, Astra Zeneca, Takeda, Astellas, etc.), and through the design and optimization of the original dosage form, the bioavailability and safety of the drug are improved. The cooperation areas cover professional fields such as tumors, respiratory, kidney disease, rare diseases, anti-infection, and mental illness. The persistent pursuit of product quality has made NIPRO highly evaluated in the global clinical medical field. Especially in the fields of nephrological artificial organs and regenerative medicine, NIPRO has become a world-leading brand. Nipulo Trading (Shanghai) Co., Ltd. was officially established in Shanghai in 2003. It is mainly engaged in the sales of Nipro related products in the Chinese market. NIPRO has gained the trust and support of more and more clinical experts with its high-quality products and continuous improvement services. China in the early 1990s lacked foreign currency, and it was very difficult to buy dialysis machines and dialyzers from Japan at the same time. Nipulo Shanghai Contact Office (the predecessor of Nipulo Trading (Shanghai) Co., Ltd.) has helped China clinically carry out dialysis treatment since 1993, and has given dialysis machines to 10 Chinese hospitals for free, so many patients were treated, which also made the hospital. Saved a lot of money.
Nipro Trading (Shanghai) Co., Ltd.
NIPRO is at the forefront of global medical care and constantly challenges the unknown areas of life sciences. With persistent commitment to the research and development and innovation of cutting-edge medical products, NIPRO has been able to provide excellent technologies and products for various fields such as medical equipment and medicines. A variety of patented technologies used in artificial kidneys and various disposable medical devices give this medical product unprecedented functions and characteristics. NIPRO has also carried out close cooperation with many multinational pharmaceutical companies (Pfizer, Novartis, Astra Zeneca, Takeda, Astellas, etc.), and through the design and optimization of the original dosage form, the bioavailability and safety of the drug are improved. The cooperation areas cover professional fields such as tumors, respiratory, kidney disease, rare diseases, anti-infection, and mental illness. The persistent pursuit of product quality has made NIPRO highly evaluated in the global clinical medical field. Especially in the fields of nephrological artificial organs and regenerative medicine, NIPRO has become a world-leading brand. Nipulo Trading (Shanghai) Co., Ltd. was officially established in Shanghai in 2003. It is mainly engaged in the sales of Nipro related products in the Chinese market. NIPRO has gained the trust and support of more and more clinical experts with its high-quality products and continuous improvement services. China in the early 1990s lacked foreign currency, and it was very difficult to buy dialysis machines and dialyzers from Japan at the same time. Nipulo Shanghai Contact Office (the predecessor of Nipulo Trading (Shanghai) Co., Ltd.) has helped China clinically carry out dialysis treatment since 1993, and has given dialysis machines to 10 Chinese hospitals for free, so many patients were treated, which also made the hospital. Saved a lot of money.
Introcan Safety is a safety IV catheter designed to protect healthcare workers from needlestick injuries.
B. Braun Melsungen AG
Introcan Safety is a safety IV catheter designed to protect healthcare workers from needlestick injuries.
Becton, Dickinson and Company
Nexiva is a closed IV catheter system that reduces the risk of needlestick injuries and blood exposure.
Becton, Dickinson and Company
Nexiva is a closed IV catheter system that reduces the risk of needlestick injuries and blood exposure.
Becton, Dickinson and Company
Angiocath offers a range of IV catheters designed for ease of use and patient comfort.
Becton, Dickinson and Company
Angiocath offers a range of IV catheters designed for ease of use and patient comfort.
Becton, Dickinson and Company
Insyte Pro is a professional-grade IV catheter that offers advanced features for healthcare professionals.
Becton, Dickinson and Company
Insyte Pro is a professional-grade IV catheter that offers advanced features for healthcare professionals.
